Literature DB >> 11846557

Importance of the conserved CA dinucleotide at Mu termini.

I Lee1, R M Harshey.   

Abstract

The dinucleotide CA found at the termini of transposable phage Mu also occurs at the termini of a large class of transposable elements, including HIV, all retroviruses and many retrotransposons. In order to understand the importance of this sequence conservation, the activity of all 16 dinucleotide permutations of the termini was first examined using a sensitive plasmid-based in vivo transposition assay. The reactivity of these substrates varied over several orders of magnitude in vivo, with substitutions at the A position being more severely impaired than those at the C position. The same general hierarchy of reactivity was observed in vitro using mutant oligonucleotide substrates. These experiments revealed that CA was not important for the chemistry of strand transfer, and that the block in the activity of the mutant substrates was at the stage of assembly of a stable transpososome. Given that DNA at the Mu-host junctions is melted/distorted concomitantly with transpososome assembly, we consider the hypothesis that the CA dinucleotide has been selected at transposon termini primarily for its significant conformational mobility. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11846557     DOI: 10.1006/jmbi.2001.5177

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  The terminal nucleotide of the Mu genome controls catalysis of DNA strand transfer.

Authors:  Ilana Goldhaber-Gordon; Michael H Early; Tania A Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-09       Impact factor: 11.205

2.  Patterns of sequence conservation at termini of long terminal repeat (LTR) retrotransposons and DNA transposons in the human genome: lessons from phage Mu.

Authors:  Insuk Lee; Rasika M Harshey
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

3.  Controlling DNA degradation from a distance: a new role for the Mu transposition enhancer.

Authors:  Wonyoung Choi; Rudra P Saha; Sooin Jang; Rasika M Harshey
Journal:  Mol Microbiol       Date:  2014-09-25       Impact factor: 3.501

Review 4.  Transposable Phage Mu.

Authors:  Rasika M Harshey
Journal:  Microbiol Spectr       Date:  2014-10

5.  Analysis of phage Mu DNA transposition by whole-genome Escherichia coli tiling arrays reveals a complex relationship to distribution of target selection protein B, transcription and chromosome architectural elements.

Authors:  Jun Ge; Zheng Lou; Hong Cui; Lei Shang; Rasika M Harshey
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

6.  Crucial role of CA cleavage sites in the cap-snatching mechanism for initiating viral mRNA synthesis.

Authors:  Ping Rao; Weiming Yuan; Robert M Krug
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

7.  Classification of COVID-19 and Other Pathogenic Sequences: A Dinucleotide Frequency and Machine Learning Approach.

Authors:  Gciniwe S Dlamini; Stephanie J Muller; Rebone L Meraba; Richard A Young; James Mashiyane; Tapiwa Chiwewe; Darlington S Mapiye
Journal:  IEEE Access       Date:  2020-10-15       Impact factor: 3.367

8.  Excision of Sleeping Beauty transposons: parameters and applications to gene therapy.

Authors:  Geyi Liu; Elena L Aronovich; Zongbin Cui; Chester B Whitley; Perry B Hackett
Journal:  J Gene Med       Date:  2004-05       Impact factor: 4.565

9.  Congruence of in vivo and in vitro insertion patterns in hot E. coli gene targets of transposable element Mu: opposing roles of MuB in target capture and integration.

Authors:  Jun Ge; Rasika M Harshey
Journal:  J Mol Biol       Date:  2008-05-20       Impact factor: 5.469

Review 10.  Integrase and integration: biochemical activities of HIV-1 integrase.

Authors:  Olivier Delelis; Kevin Carayon; Ali Saïb; Eric Deprez; Jean-François Mouscadet
Journal:  Retrovirology       Date:  2008-12-17       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.